EVAX Evaxion A/S
$3.11▲ +2.30%
Healthcare
Other
Volume 51.0K
Avg Volume (10D) 204.9K
Key Metrics & Fundamentals
Market Cap
$28.06M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.72 - 6.92
% vs 50 MA
-2.54%
% vs 200 MA
-11.70%
RSI-14
47.0
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.48
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.82M
COGS
–
Operating Exp
$3.85M
Operating Income
-$3.85M
EBIT
-$3.85M
Pretax Income
-$3.93M
Net Income
-$3.73M
EPS (Diluted)
-0.50
Price & Volume History
Loading chart…
Recent News
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
MT Newswires · Oct 27, 2026 11:13 AM ET
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
MT Newswires · Oct 26, 2026 11:12 AM ET
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
MT Newswires · Oct 23, 2026 11:11 AM ET
EVAX Stock Heads For Best Week Since January 2025 As Cancer Vaccine Shows 89% Target Precision
Stocktwits · Oct 23, 2026 7:15 AM ET
Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
GlobeNewswire · Oct 23, 2026 2:00 AM ET
European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
MT Newswires · Oct 21, 2026 11:11 AM ET
European Equities Traded in the US as American Depositary Receipts Advance in Tuesday Trading
MT Newswires · Oct 20, 2026 11:10 AM ET
Evaxion stock surges on 3-year melanoma vaccine trial data
Investing.com · Oct 19, 2026 12:58 PM ET
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
MT Newswires · Oct 19, 2026 11:13 AM ET
INTC, EVAX, RCAT Stocks Move Higher Premarket — What’s Driving The Rally?
Stocktwits · Oct 19, 2026 6:27 AM ET
Financial Overview - Income Statement
Quarterly
Sep 2025
See EVAX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.